Free Trial

TransMedics Group (TMDX) Earnings Date, Estimates & Call Transcripts

TransMedics Group logo
$94.93 -2.15 (-2.21%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$75.17 -19.76 (-20.82%)
As of 04:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TransMedics Group Earnings Summary

TransMedics Group issued Q1 2026 earnings on May 5, 2026, reporting an EPS of $0.30, which missed the consensus estimate of $0.62 by $0.32. Quarterly revenue rose 21.2% year-over-year to $173.93 million, below analysts' expectations of $174.48 million. With a trailing EPS of $4.90 and a P/E Ratio of 19.37, TransMedics Group's earnings are expected to grow 54.44% next year, from $2.48 to $3.83 per share.

Latest Q1
Earnings Date
May. 5Estimated
Consensus EPS
(May. 5)
$0.62
Actual EPS
(May. 5)
$0.30 Missed By -$0.32
Actual Revenue
(May. 5)
$173.93M

Q1 2026 Earnings Resources

Get TransMedics Group Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TransMedics Group and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

TMDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TMDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TransMedics Group Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20261$0.63$0.63$0.63
Q2 20261$0.59$0.59$0.59
Q3 20261$0.65$0.65$0.65
Q4 20261$0.58$0.58$0.58

TransMedics Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026$0.62$0.30 -$0.32$0.20$174.48M$173.93M
10/29/2025Q3 2025$0.37$0.66+$0.29$0.66$145.33M$143.82M
7/30/2025Q2 2025$0.48$0.92+$0.44$0.92$146.64M$157.37M
5/8/2025Q1 2025$0.29$0.70+$0.41$0.70$123.39M$143.54M
10/28/2024Q3 2024$0.29$0.12 -$0.17$0.12$115.00M$108.76M
7/31/2024Q2 2024$0.21$0.35+$0.14$0.35$98.84M$114.30M

Data powered by Fiscal.ai.

TransMedics Group Earnings - Frequently Asked Questions

TransMedics Group (NASDAQ:TMDX) last announced its quarterly earning data on Tuesday, May 5, 2026. Learn more on TMDX's earnings history.

TransMedics Group issued an update on its FY 2026 earnings guidance on Tuesday, May, 5th. The company issued revenue guidance of $727.0 million-$757.0 million, compared to the consensus revenue estimate of $739.2 million.

In the previous quarter, TransMedics Group (NASDAQ:TMDX) missed the analysts' consensus estimate of $0.62 by $0.32 with a reported earnings per share (EPS) of $0.30. Learn more on analysts' earnings estimate vs. TMDX's actual earnings.

The conference call for TransMedics Group's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for TransMedics Group's latest earnings report can be read online.
Read Transcript

TransMedics Group (NASDAQ:TMDX) has a recorded annual revenue of $605.49 million.

TransMedics Group (NASDAQ:TMDX) has a recorded net income of $190.29 million. TMDX has generated $4.90 earnings per share over the last four quarters.

TransMedics Group (NASDAQ:TMDX) has a trailing price-to-earnings ratio of 19.37 and a forward price-to-earnings ratio of 38.28.

TransMedics Group's earnings are expected to grow from $2.48 per share to $3.83 per share in the next year, which is a 54.44% increase.


This page (NASDAQ:TMDX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners